ArticleFrontiers in oncology2025
Engineered celastrol liposomes with glycyrrhizic acid augment synergistic antitumor efficacy in breast cancer.
Wei Zhang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it